News | January 27, 2026
Hester receives manufacturing license for inactivated avian influenza vaccine for poultry
This license is a key regulatory milestone in advancing Hester's prevention-led poultry healthcare portfolio
This license is a key regulatory milestone in advancing Hester's prevention-led poultry healthcare portfolio
Galenicum will oversee development, manufacturing and supply, while Lupin will handle regulatory submissions, approvals, and commercialization and distribution of Semaglutide across 23 countries globally
Under the 2023 collaboration agreement, Assembly Bio will receive $35 million for Gilead’s exercise of the HSV program option
The antibody was designed and developed at Abzena’s Cambridge, UK,
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
The sudden subsequent decision to suspend IXCHIQ is based on updated VAERS data
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
his is the second license extension of a Nurix autoimmune disease program by Sanofi in the last 90 days
Subscribe To Our Newsletter & Stay Updated
